HIV 1 News and Research

RSS

Shared needle at school science experiment puts students at risk

In a science experiment at a Tasmanian Dover District high school, a teacher took blood samples from grade 9 and 10 students using the same needle. They were testing blood pH levels. Now students are being tested for HIV infection. The needle was dipped in methylated spirits each time before pricking but authorities say this is not enough to prevent transmission of HIV and other viruses like Hepatitis B and C.

8 Sep 2010

AHF praises US government's increase in PEPFAR funding commitment for Uganda

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, which currently cares for over 49,000 AIDS patients in Uganda through its Uganda CARES network of eleven treatment clinics throughout the country, today lauded the United States government for increasing its funding commitment in Uganda for the President's Emergency Plan for AIDS Relief (PEPFAR), the United States' respected global AIDS program.

8 Sep 2010

AVAC welcomes new Global HIV Vaccine Enterprise Scientific Strategic Plan

AVAC welcomes the new Global HIV Vaccine Enterprise Scientific Strategic Plan, released today, as a critical document that the field must implement as part of ongoing efforts to improve coordination, efficiency and transparency to quickly capitalize on recent advances in AIDS vaccine research.

8 Sep 2010

Experts gathered for UNAIDS, WHO meeting recommend follow-up studies of ARV-containing microbicide gel start soon

Experts gathered at a joint meeting of UNAIDS and the WHO last week called for two additional clinical trials to test the effectiveness and safety of a microbicide vaginal gel containing the antiretroviral tenofovir, which previous studies have shown reduces the risk of HIV transmission in women who used it before and after sex by 39 percent, PANA/Afrique en ligne reports (9/5).

8 Sep 2010

La Jolla Pharmaceutical seeks clinical product for lupus treatment

La Jolla Pharmaceutical Company provided an update today that the Company is actively seeking and evaluating potential pharmaceutical products for in-licensing or acquisition and has engaged consultants to determine whether there is any potential for the further development of Riquent for the treatment of lupus.

8 Sep 2010

Switching to nevirapine drug from PI based regimen reduces viremia in children: Study

HIV infected children in South Africa who were exposed to the drug nevirapine at birth (used to help prevent mother to child HIV transmission) and then received a protease inhibitor (PI) for viral suppression achieved lower rates of viremia (virus in the blood stream) if they were switched to nevirapine, compared to children who continued on the PI-based regimen, according to a study in the September 8 issue of JAMA.

8 Sep 2010

Also in Global Health News: India's antibiotic use; Abstinence curriculum in China; Child, maternal health in India; Plumpy'nut; PEPFAR funds to Uganda

"The health ministry has formed a committee to frame a policy for antibiotic use, following an uproar over a Lancet study that traced a drug-resistant bacterial superbug's origins to India," LiveMint.com reports. The panel will also look into the "excessive use of antibiotics among Indians," partly fueled by self-medication, that has increased resistance to the drugs. The article notes that the Indian government "rejected the findings of the report" but has "taken note of a lack of policy on antibiotics" (Pandeya, 9/3).

7 Sep 2010

Teleflex partners with Access Scientific to distribute The PICC WAND vascular access device

Teleflex has partnered with Access Scientific Incorporated, San Diego, California to become the U.S. distributor of The PICC WAND™ Safety Introducer with ARROW® peelable sheath. This new, all- in-one vascular access device provides clinicians a faster, safer, simpler way to insert a peel away sheath for PICC or Midline catheter placements.

7 Sep 2010

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Bruker Corporation announces a major order from the University of Maryland School of Medicine for its ultra-high field AVANCE III 950 US2 NMR spectrometer. The 950 MHz Nuclear Magnetic Resonance magnet and spectrometer will help University of Maryland researchers to unravel the mysteries of molecules and develop new agents to treat cancer, AIDS and other diseases.

7 Sep 2010

Subset of gay community continues to contribute to HIV spread: Research

Risky sexual behavior among members of a subset of the gay community is still adding to the spread of HIV. Research published in the open access journal BMC Infectious Diseases has found that young white homosexual men have an important contribution in the local spread of HIV.

7 Sep 2010

Cairns forum to discuss PNG issues

James Cook University's (JCU) Papua New Guinea and Pacific Research Forum from the Pacific Island Nations will be discussing the issues affecting the region at Cairns in far north Queensland today. Academics as well as policy makers are likely to convene at the forum.

5 Sep 2010

Human endogenous retroviruses may provide insight evidence to HIV diagnosis

Why is it so hard to isolate and purify human immunodeficiency virus (HIV).Why has no one been able to see, by electron microscopy, a single HIV particle in the blood of AIDS patients, even those who have a "high viral load" Why does HIV seem to mutate with startling rapidity. AIDS researchers have not been able to come up with answers to these questions.

4 Sep 2010

IAS urges to review guidelines for implementing HIV prevention and care

Following the imprisonment of Maxim Popov in April 2010, sentenced to 7 years jail primarily for the promotion of HIV prevention efforts in Uzbekistan, the International AIDS Society (IAS) notes with alarm the detention of a medial practitioner working in HIV prevention in Ukraine.

4 Sep 2010

VOA News examines U.S. Global Health Initiative

VOA News examines President Barack Obama's $63 billion Global Health Initiative (GHI), noting the initiative's emphasis on cost-effective strategies to improve child- and maternal-health as well as programs to fight HIV/AIDS, tuberculosis (TB) and malaria. The article includes recent comments by Secretary of State Hillary Rodham Clinton on the role the GHI will play in strengthening health systems and the administration's on-going commitment to global HIV/AIDS programs.

4 Sep 2010

AVAC calls for economic and political support for CAPRISA 004 microbicide trial's critical follow-up studies

AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only $58 million has been committed.

4 Sep 2010

State News: Ohio, Florida take advantage of federal health funds; Mass. psychiatrists win court case

The Columbus Dispatch: "Gov. Ted Strickland's administration announced today that nearly $200 million in recently freed up state funds will go to Ohio hospitals, community mental health services, and a program which provides medication to low-income residents with HIV/AIDS. … The state money became available after Congress agreed to continue paying a higher share of the cost of state Medicaid programs that provide insurance coverage to the poor.

3 Sep 2010

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency

Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults.

3 Sep 2010

WHO revises treatment protocols for HIV patients

Prompted by clinical research into the early initiation of antiretroviral therapies for HIV performed at the GHESKIO clinic in Port-au-Prince, Haiti, the World Health Organization (WHO) has revised its treatment protocols for HIV patients.

3 Sep 2010

Commitments to global HIV/AIDS programs falter for 'first time in 15 years,' UNAIDS chief says

UNAIDS Executive Director Michel Sidibe "said Thursday that global contributions to fighting [HIV/AIDS] are dropping off for the first time in 15 years amid tough economic times," Agence France-Presse reports.

3 Sep 2010

Researchers find role of Vpr protein in HIV infection

Dr. Éric A. Cohen, Director of the Human Retrovirology research unit at the Institut de recherches cliniques de Montréal (IRCM), and his team published yesterday, in the online open-access journal PLos Pathogens, the results of their most recent research on the role of the Vpr protein in HIV (human immunodeficiency virus) infection and AIDS (acquired autoimmune deficiency syndrome).

3 Sep 2010

HIV 1 News and Research

Shared needle at school science experiment puts students at risk

AHF praises US government's increase in PEPFAR funding commitment for Uganda

AVAC welcomes new Global HIV Vaccine Enterprise Scientific Strategic Plan

Experts gathered for UNAIDS, WHO meeting recommend follow-up studies of ARV-containing microbicide gel start soon

La Jolla Pharmaceutical seeks clinical product for lupus treatment

Switching to nevirapine drug from PI based regimen reduces viremia in children: Study

Also in Global Health News: India's antibiotic use; Abstinence curriculum in China; Child, maternal health in India; Plumpy'nut; PEPFAR funds to Uganda

Teleflex partners with Access Scientific to distribute The PICC WAND vascular access device

University of Maryland School of Medicine orders AVANCE III 950 US2 NMR spectrometer from Bruker

Subset of gay community continues to contribute to HIV spread: Research

Cairns forum to discuss PNG issues

Human endogenous retroviruses may provide insight evidence to HIV diagnosis

IAS urges to review guidelines for implementing HIV prevention and care

VOA News examines U.S. Global Health Initiative

AVAC calls for economic and political support for CAPRISA 004 microbicide trial's critical follow-up studies

State News: Ohio, Florida take advantage of federal health funds; Mass. psychiatrists win court case

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency

WHO revises treatment protocols for HIV patients

Commitments to global HIV/AIDS programs falter for 'first time in 15 years,' UNAIDS chief says

Researchers find role of Vpr protein in HIV infection

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News